Evidence map›Paper›PMID 29471411›Full record

ArticleThe international journal of neuropsychopharmacology2018

Mechanisms Underpinning the Polypharmacy Effects of Medications in Psychiatry.

Chiara C Bortolasci, Briana Spolding, Edward Callaly, Sheree Martin, Bruna Panizzutti, Srisaiyini Kidnapillai, Timothy Connor, Kyoko Hasebe, Mohammadreza Mohebbi, Olivia M Dean and 5 more

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Effects of Psychotropic Drugs on Ribosomal Genes and Protein Synthesis.International journal of molecular sciences · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Chiara C BortolasciCentre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, VIC, Australia.
Briana SpoldingCentre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, VIC, Australia.
Edward CallalyCentre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, VIC, Australia.
Sheree MartinCentre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, VIC, Australia.
Bruna PanizzuttiLaboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre and Programa de Pós-graduação em Psiquiatria e Ciências do Comportamento, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Srisaiyini KidnapillaiCentre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, VIC, Australia.
Timothy ConnorCentre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, VIC, Australia.
Kyoko HasebeCentre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, VIC, Australia.
Mohammadreza MohebbiBiostatistics Unit, Deakin University, Geelong, VIC, Australia.
Olivia M DeanThe Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
Sean L McGeeCentre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, VIC, Australia.
Seetal DoddThe Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
Laura GrayCentre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, VIC, Australia.
Michael BerkThe Florey Institute of Neuroscience and Mental Health, Parkville, VIC, Australia.
Ken WalderCentre for Molecular and Medical Research, School of Medicine, Deakin University, Geelong, VIC, Australia.
Deakin University · AUUniversidade Estadual de Londrina · BRUniversidade Federal do Rio Grande do Sul · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Bipolar disorder is a mental health condition with progressive social and cognitive function disturbances. Most patients' treatments are based on polypharmacy, but with no biological basis and little is known of the drugs' interactions. The aim of this study was to analyze the effects of lithium, valproate, quetiapine, and lamotrigine, and the interactions between them, on markers of inflammation, bioenergetics, mitochondrial function, and oxidative stress in neuron-like cells and microglial cells. Methods: Neuron-like cells and lipopolysaccharide-stimulated C8-B4 cells were treated with lithium (2.5 mM), valproate (0.5 mM), quetiapine (0.05 mM), and lamotrigine (0.05 mM) individually and in all possible combinations for 24 h. Twenty cytokines were measured in the media from lipopolysaccharide-stimulated C8-B4 cells. Metabolic flux analysis was used to measure bioenergetics, and real-time PCR was used to measure the expression of mitochondrial function genes in neuron-like cells. The production of superoxide in treated cells was also assessed. Results: The results suggest major inhibitory effects on proinflammatory cytokine release as a therapeutic mechanism of these medications when used in combination. The various combinations of medications also caused overexpression of PGC1α and ATP5A1 in neuron-like cells. Quetiapine appears to have a proinflammatory effect in microglial cells, but this was reversed by the addition of lamotrigine independent of the drug combination. Conclusion: Polypharmacy in bipolar disorder may have antiinflammatory effects on microglial cells as well as effects on mitochondrial biogenesis in neuronal cells.

Indexed as

AnimalsAntimanic AgentsBipolar DisorderCell LineCytokinesDrug InteractionsGene ExpressionHumansInflammationLipopolysaccharidesMiceMicrogliaMitochondriaNeuronsPolypharmacyAntimanic AgentsCytokinesLipopolysaccharides

Identifiers

PMID29471411
PMCPMC6007392
OpenAlexW2790951755

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.